Report from a consensus conference on the sensitized patient awaiting heart transplantation.
作者信息
Kobashigawa Jon, Mehra Mandeep, West Lori, Kerman Ronald, George James, Rose Marlene, Zeevi Adriana, Reinsmoen Nancy, Patel Jignesh, Reed Elaine F
机构信息
David Geffen School of Medicine at UCLA, Los Angeles, California, USA.
出版信息
J Heart Lung Transplant. 2009 Mar;28(3):213-25. doi: 10.1016/j.healun.2008.12.017.
Abstract
摘要
相似文献
1
Report from a consensus conference on the sensitized patient awaiting heart transplantation.
J Heart Lung Transplant. 2009 Mar;28(3):213-25. doi: 10.1016/j.healun.2008.12.017.
2
Antibody-mediated rejection in cardiac transplantation: emerging knowledge in diagnosis and management: a scientific statement from the American Heart Association.
Circulation. 2015 May 5;131(18):1608-39. doi: 10.1161/CIR.0000000000000093. Epub 2015 Apr 2.
3
Improving survival during heart transplantation: diagnosis of antibody-mediated rejection and techniques for the prevention of graft injury.
Future Cardiol. 2012 Jul;8(4):623-35. doi: 10.2217/fca.12.27.
4
Reduction of alloantibodies via proteasome inhibition in cardiac transplantation.
J Heart Lung Transplant. 2011 Dec;30(12):1320-6. doi: 10.1016/j.healun.2011.08.009. Epub 2011 Oct 2.
5
Graft rejection in sensitized recipients.
Ann Transplant. 1996;1(1):34-40.
6
The Pre-Transplant Drop in Panel-Reactive Antibodies Titer Evaluated Using Complement-Dependent Cytotoxicity (PRA-CDC) and the Risk of Early Acute Rejection in Sensitized Kidney Transplant Recipients.
Medicina (Kaunas). 2018 Sep 20;54(5):66. doi: 10.3390/medicina54050066.
7
Antibody-mediated rejection of the pancreas allograft.
Transplantation. 2009 Jul 27;88(2):292-3. doi: 10.1097/TP.0b013e3181acc9b8.
8
Immunosuppression in the sensitized heart transplant recipient.
Curr Opin Organ Transplant. 2010 Oct;15(5):650-6. doi: 10.1097/MOT.0b013e32833de9b2.
9
Alloantibodies restore cardiac allograft rejection to IgKO mice.
Transplant Proc. 2001 Feb-Mar;33(1-2):317. doi: 10.1016/s0041-1345(00)02025-x.
10
Cardiac antibody-mediated rejection.
Pediatr Transplant. 2012 Aug;16(5):404-12. doi: 10.1111/j.1399-3046.2012.01690.x. Epub 2012 Apr 15.
引用本文的文献
1
Heart Transplant Rejection: From the Endomyocardial Biopsy to Gene Expression Profiling.
Biomedicines. 2024 Aug 22;12(8):1926. doi: 10.3390/biomedicines12081926.
2
Rejection Requiring Treatment within the First Year following Heart Transplantation: The UNOS Insight.
J Pers Med. 2023 Dec 29;14(1):52. doi: 10.3390/jpm14010052.
3
Position Statement on Ischemic Heart Disease - Women-Centered Health Care - 2023.
Arq Bras Cardiol. 2023 Aug 4;120(7):e20230303. doi: 10.36660/abc.20230303.
4
Heart Transplant Immunosuppression Strategies at Cedars-Sinai Medical Center.
Int J Heart Fail. 2020 Sep 29;3(1):15-30. doi: 10.36628/ijhf.2020.0034. eCollection 2021 Jan.
5
Management of the sensitized pediatric heart transplant patient.
Transl Pediatr. 2019 Oct;8(4):302-313. doi: 10.21037/tp.2019.07.13.
6
Impact of pretransplant antibodies on outcomes after heart transplantation.
Curr Opin Organ Transplant. 2019 Jun;24(3):220-226. doi: 10.1097/MOT.0000000000000629.
7
Recent advances in heart transplantation.
F1000Res. 2018 Jul 5;7. doi: 10.12688/f1000research.14737.1. eCollection 2018.
8
The Past, Present and Future of Heart Transplantation.
Korean Circ J. 2018 Jul;48(7):565-590. doi: 10.4070/kcj.2018.0189.
9
Ventricular assist device elicits serum natural IgG that correlates with the development of primary graft dysfunction following heart transplantation.
J Heart Lung Transplant. 2017 Aug;36(8):862-870. doi: 10.1016/j.healun.2017.03.018. Epub 2017 Mar 24.
10
Desensitization Strategies Pre- and Post-Cardiac Transplantation.
Curr Treat Options Cardiovasc Med. 2016 Feb;18(2):8. doi: 10.1007/s11936-015-0431-9.
本文引用的文献
1
Sensitivity, specificity and clinical relevance of different cross-matching assays in deceased-donor renal transplantation.
Transpl Immunol. 2008 Nov;20(1-2):61-7. doi: 10.1016/j.trim.2008.09.013. Epub 2008 Oct 16.
2
Detecting and monitoring human leukocyte antigen-specific antibodies.
Hum Immunol. 2008 Oct;69(10):591-604. doi: 10.1016/j.humimm.2008.06.013. Epub 2008 Aug 8.
3
Allosensitization in bridge to transplant Novacor left ventricular assist device patients: analysis of long-term outcomes with regard to acute rejection and chronic allograft vasculopathy.
Eur J Cardiothorac Surg. 2008 Aug;34(2):268-74; discussion 274. doi: 10.1016/j.ejcts.2008.03.063. Epub 2008 May 23.
4
Clinical importance of anti-human leukocyte antigen-specific antibody concentration in performing calculated panel reactive antibody and virtual crossmatches.
Transplantation. 2008 Apr 15;85(7):1046-50. doi: 10.1097/TP.0b013e318168fdb5.
5
HLA class I antibody-mediated endothelial cell proliferation via the mTOR pathway.
J Immunol. 2008 Feb 15;180(4):2357-66. doi: 10.4049/jimmunol.180.4.2357.
6
DP reactive antibody in a zero mismatch renal transplant pair.
Hum Immunol. 2007 Dec;68(12):947-9. doi: 10.1016/j.humimm.2007.10.013. Epub 2007 Nov 26.
7
Early screening for antibody-mediated rejection in heart transplant recipients.
J Heart Lung Transplant. 2007 Dec;26(12):1264-9. doi: 10.1016/j.healun.2007.09.011. Epub 2007 Nov 26.
8
Influence of pretransplant panel-reactive antibody on outcomes in 8,160 heart transplant recipients in recent era.
Ann Thorac Surg. 2007 Nov;84(5):1556-62; discussion 1562-3. doi: 10.1016/j.athoracsur.2007.05.095.
9
C4d fixing, luminex binding antibodies - a new tool for prediction of graft failure after heart transplantation.
Am J Transplant. 2007 Dec;7(12):2809-15. doi: 10.1111/j.1600-6143.2007.01991.x. Epub 2007 Oct 1.
10
Antibodies against MICA antigens and kidney-transplant rejection.
N Engl J Med. 2007 Sep 27;357(13):1293-300. doi: 10.1056/NEJMoa067160.
Zotero 插件